GRI Bio, Inc.
GRI
$1.80
-$0.20-10.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -24.42% | 58.95% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -17.72% | -24.81% | |||
| Operating Income | 17.72% | 24.81% | |||
| Income Before Tax | 17.77% | 24.86% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 17.77% | 24.86% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 17.77% | 24.86% | |||
| EBIT | 17.72% | 24.81% | |||
| EBITDA | 17.68% | 24.82% | |||
| EPS Basic | 43.46% | 87.85% | |||
| Normalized Basic EPS | 43.46% | 87.85% | |||
| EPS Diluted | 43.46% | 87.85% | |||
| Normalized Diluted EPS | 43.46% | 87.85% | |||
| Average Basic Shares Outstanding | 45.45% | 518.34% | |||
| Average Diluted Shares Outstanding | 45.45% | 518.34% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||